# Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial Fibrillation

> **NCT06111443** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 196 (estimated)

## Conditions studied

- Atrial Fibrillation Recurrent
- Catheter Ablation

## Interventions

- **DRUG:** Dapagliflozin 10 mg [Farxiga]

## Key facts

- **NCT ID:** NCT06111443
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-12-01
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2023-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06111443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06111443, "Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial Fibrillation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06111443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*